Publications by authors named "Claudio Papi"

Claim this Profile
P
Post-Discharge Outcomes of Elderly Patients Hospitalized for Inflammatory Bowel Disease Flare Complicated by Clostridioides difficile Infection.
Idan Goren, Ortal Fallek Boldes, Tomer Boldes, Oleg Knyazev, Anna Kagramanova, Claudio Papi

J Crohns Colitis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in Medical Management of Inflammatory Bowel Disease and Reducing Surgical Risk: Investigating Causality Through the Bradford-Hill Criteria.
Daniela Maggi, Claudio Papi, Stefano Festa, Annalisa Aratari

J Clin Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crohn's disease after surgery: Changes in post-operative management strategies over time and their impact on long-term re-operation rate-A retrospective multicentre real-world study.
Annalisa Aratari, Maria Lia Scribano, Daniela Pugliese, Valentina Baccolini, Fabiola De Biasio, Claudio Papi

Aliment Pharmacol Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus.
Fabio Salvatore Macaluso, Flavio Caprioli, Laura Benedan, Cristina Bezzio, Roberto Caporali, Claudio Papi

Autoimmun Rev· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noninvasive Assessment of Postoperative Disease Recurrence in Crohn's Disease: A Multicenter, Prospective Cohort Study on Behalf of the Italian Group for Inflammatory Bowel Disease.
Federica Furfaro, Ferdinando D'Amico, Alessandra Zilli, Vincenzo Craviotto, Annalisa Aratari, Claudio Papi

Clin Gastroenterol Hepatol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stricturing Crohn's disease: what is the role of endoscopic stenting? A systematic review.
Giorgia Burrelli Scotti, Roberto Lorenzetti, Annalisa Aratari, Antonietta Lamazza, Enrico Fiori, Claudio Papi

Clin Endosc· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author's Reply: ``Use of biologics for the management of Crohn's disease''.
Stefanos Bonovas, Fabio Salvatore Macaluso, Daniele Piovani, Claudio Papi, Ambrogio Orlando

Dig Liver Dis· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of biologics for the management of Crohn's disease: IG-IBD technical review based on the GRADE methodology.
Stefanos Bonovas, Daniele Piovani, Claudia Pansieri, Fabio Salvatore Macaluso, Ambrogio Orlando, Claudio Papi

Dig Liver Dis· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of biologics for the management of Crohn's disease: IG-IBD clinical guidelines based on the GRADE methodology.
Fabio Salvatore Macaluso, Claudio Papi, Ambrogio Orlando, Stefano Festa, Daniela Pugliese

Dig Liver Dis· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Should the Mediterranean diet be recommended for inflammatory bowel diseases patients? A narrative review.
Alicja Ewa Ratajczak, Stefano Festa, Annalisa Aratari, Claudio Papi, Agnieszka Dobrowolska

Front Nutr· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intentional treatment with tofacitinib in a patient with severe refractory ulcerative colitis and concomitant Sars-CoV-2 infection.
Stefano Festa, Fabiola De Biasio, Annalisa Aratari, Claudio Papi

Dig Liver Dis· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Effectiveness Research: A Roadmap to Sail the Seas of IBD Therapies.
Daniela Pugliese, Sara Onali, Giuseppe Privitera, Alessandro Armuzzi, Claudio Papi

J Clin Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gastroenteropancreatic Neuroendocrine Neoplasms in Patients with Inflammatory Bowel Disease: An ECCO CONFER Multicentre Case Series.
Stefano Festa, Giulia Zerboni, Lauranne A A P Derikx, Davide Giuseppe Ribaldone, Gabriele Dragoni, Claudio Papi

J Crohns Colitis· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD technical review based on the GRADE methodology.
Stefanos Bonovas, Claudia Pansieri, Daniele Piovani, Fabio Salvatore Macaluso, Ambrogio Orlando, Claudio Papi

Dig Liver Dis· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodology.
Fabio Salvatore Macaluso, Ambrogio Orlando, Claudio Papi, Stefano Festa, Daniela Pugliese

Dig Liver Dis· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of ustekinumab in patients with refractory Crohn's disease: a multicentre real-life study in Italy.
Maria Lia Scribano, Annalisa Aratari, Benedetto Neri, Cristina Bezzio, Paola Balestrieri, Claudio Papi

Therap Adv Gastroenterol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incident Colorectal Cancer in Inflammatory Bowel Disease.
Benedetto Neri, Maria Lia Scribano, Alessandro Armuzzi, Fabiana Castiglione, Renata D'Incà, Claudio Papi

Cancers (Basel)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No impact of restructuring IBD-related activity during COVID-19 outbreak on patient outcomes. A single Center experience.
Fabiola De Biasio, Annalisa Aratari, Stefano Festa, Roberto Lorenzetti, Claudio Papi

Dig Liver Dis· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study.
Stefano Festa, Maria L Scribano, Daniela Pugliese, Cristina Bezzio, Mariabeatrice Principi, Claudio Papi

United European Gastroenterol J· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What are the challenges in selecting pharmacotherapy for pregnant women with inflammatory bowel disease?
Annalisa Aratari, Giulia Zerboni, Fabiola De Biasio, Angelo Viscido, Claudio Papi

Recenti Prog Med· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening for active COVID-19 infection prior to biologic therapy in IBD patients: Let's not increase our uncertainty without reducing our concerns.
Stefano Festa, Annalisa Aratari, Fabiola De Biasio, Federica Fascì-Spurio, Claudio Papi

Dig Liver Dis· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The management of inflammatory bowel diseases in the era of COVID-19 pandemic: When "non-urgent" does not mean "deferrable".
Daniela Pugliese, Claudio Papi, Giuseppe Privitera, Annalisa Aratari, Stefano Festa

Dig Liver Dis· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute kidney injury: an unexpected Isoniazid-related adverse event in a patient with Crohn's disease receiving prophylactic treatment for latent tuberculosis.
Fabiola De Biasio, Annalisa Aratari, Sara Caporuscio, Iole Simeoni, Claudio Papi

Dig Liver Dis· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability.
Paolo Giuffrida, Giovanni Arpa, Federica Grillo, Catherine Klersy, Gianluca Sampietro, Claudio Papi

Mod Pathol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early-onset versus late-onset Crohn's disease: An Italian cohort study.
Laura Cantoro, Marco Vincenzo Lenti, Rita Monterubbianesi, Michele Cicala, Diana Giannarelli, Claudio Papi

United European Gastroenterol J· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis